Baseline severe anaemia should not preclude use of zidovudine in antiretroviral‐eligible patients in resource‐limited settings
Background Stavudine is no longer recommended as part of first‐line therapy for patients initiating antiretroviral therapy (ART) in Uganda. Most patients are currently initiated on zidovudine‐containing regimens, which can induce anaemia. We investigated the risk factors for early severe anaemia in...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2010-01-01
|
| Series: | Journal of the International AIDS Society |
| Online Access: | https://doi.org/10.1186/1758-2652-13-42 |